Traitement pharmacologique : enfin une solution adaptÃ© - FF3S

More documents

Recommendations

Info

Mean IELT (Min)EFFET DE PRILIGY ® (30 – 60 mg)SUR LE DÉLAI POUR ÉJACULERMean IELT by study and treatment at endpoint †*p
PRILIGY Etudes de Phase III :EP primaire et acquise efficacité comparablen = 957 n = 986 n = 955 n = 509 n = 511 n = 492 n = 957 n = 986 n = 955 n = 509 n = 511 n = 492InclusionFin d’étudeSD, standard deviation; IELT, intravaginal ejaculatory latency time; PE, premature ejaculation.aBased on pooled data from the 2 US studies, the international study, and the Asia-Pacific study.
Page 1 and 2: Physiologie etpharmacologie del’
Page 3 and 4: Emission• Composition du sperme
Page 5 and 6: S2 - S4 L5 - L3 L2 - T12Générateu
Page 7 and 8: Les solutions hors AMM
Page 9 and 10: Latence moyenne d’éjacualtion (s
Page 11 and 12: PRILIGY ® (DAPOXÉTINE)PHARMACOCIN
Page 13 and 14: DAPOXETINE (PRILIGY ® ): DEMI-VIE
Page 15 and 16: Site d’action de la dapoxétine(P
Page 17: ‘PE’ defined as an IELT of
Page 21 and 22: PRILIGY ® (30 - 60 mg) à la deman
Page 26 and 27: Priligy ® : Bon usageBrochure de b
Page 30 and 31: • Apprendre à reconnaitre PRILIG
Page 32: www.verificationmenarini.fr

Traitement pharmacologique : enfin une solution adaptÃ© - FF3S

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?